Change Language

Select Language

Press Release:

Global Asthma Therapeutics Market to Reach US$ 19.13 Billion by 2026, Spurred by Increasing Incidences of Respiratory Diseases

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Asthma Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview 2021-2026:

The global asthma therapeutics market reached a value of US$ 17.6 Billion in 2020. Looking forward, the market is expected to reach a value of US$ 19.13 Billion by 2026, expanding at a CAGR of 1.60% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Asthma therapeutics refer to various pharmaceutical drugs that are used for the treatment of asthma. Asthma is usually triggered by indoor and outdoor causative agents, including pollution, allergens and dust. These therapeutics are usually bronchodilators and anti-inflammatory drugs, which include corticosteroids, long-acting beta-agonists (LABA), methylxanthine, immunomodulators and leukotriene modifiers. A number of combination therapy drugs are also used that can be inhaled, injected, or orally administered. These drugs expand the passageway into the lungs and enable the movement of air to improve breathing. They also aid in clearing mucus from the lungs that gets coughed out with ease.

Global Asthma Therapeutics Market Trends and Drivers:

The increasing prevalence of asthma and other respiratory disorders, along with improvements in the diagnostic technologies, is one of the key factors driving the growth of the market. Furthermore, rising awareness among the masses regarding the availability of effective asthma therapeutics is also providing driving the market growth. For instance, asthmatic patients are primarily treated with inhaled corticosteroids and patients with advanced conditions or persistent asthma are treated with target-specific drugs. There is also an extensive demand for monoclonal antibodies (mAbs) that block immunoglobulin E and specific cytokines. The development of combination therapies for the treatment of respiratory diseases is acting as another growth-inducing factor. Increasing healthcare expenditures, extensive research, and development (R&D) activities in the field of medical sciences and improvements in the healthcare infrastructure are some of the other factors that are expected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global asthma therapeutics market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on drug class, product type, treatment type and route of administration.

Breakup by Drug Class:

  • Anti-Inflammatory Drugs
  • Bronchodilators
  • Combination Therapies
     

Breakup by Product Type:

  • Inhalers
    • Dry Powder Inhalers
    • Metered Dose Inhalers
    • Soft Mist Inhalers
  • Nebulizers
    • Pneumatic Nebulizers
    • Ultrasonic Nebulizers
    • Mesh Nebulizers
       

Breakup by Treatment Type:

  • Quick-Relief Medications
  • Long-Term Asthma Control Medications
     

Breakup by Route of Administration:

  • Inhalation
  • Oral
  • Parenteral
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being AstraZeneca, Abbott, Amgen Inc., Biogen Inc., Boehringer Ingelheim GmbH, F. Hoffmann-La Roche AG, GlaxoSmithKline plc., Merck & Co. Inc., Novartis AG, Sunovion Pharmaceuticals Inc. (Dainippon Sumitomo Pharma Co. Ltd.) and Teva Pharmaceutical Industries Ltd.

Report Coverage:

Report Features Details
Base Year of the Analysis 2020
Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Drug Class, Product Type, Treatment Type, Route of Administration, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered AstraZeneca, Abbott, Amgen Inc., Biogen Inc., Boehringer Ingelheim GmbH, F. Hoffmann-La Roche AG, GlaxoSmithKline plc., Merck & Co. Inc., Novartis AG, Sunovion Pharmaceuticals Inc. (Dainippon Sumitomo Pharma Co. Ltd.) and Teva Pharmaceutical Industries Ltd.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1   Preface
2   Scope and Methodology 
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction
    4.1    Overview
    4.2    Key Industry Trends
5   Global Asthma Therapeutics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Drug Class
    6.1    Anti-Inflammatory Drugs
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Bronchodilators
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Combination Therapies
        6.3.1 Market Trends
        6.3.2 Market Forecast
7   Market Breakup by Product Type
    7.1    Inhalers
        7.1.1 Market Trends
        7.1.2 Major Types 
           7.1.2.1 Dry Powder Inhalers
           7.1.2.2 Metered Dose Inhalers
           7.1.2.3 Soft Mist Inhalers
        7.1.3 Market Forecast
    7.2    Nebulizers
        7.2.1 Market Trends
        7.2.2 Major Types 
           7.2.2.1 Pneumatic Nebulizers
           7.2.2.2 Ultrasonic Nebulizers
           7.2.2.3 Mesh Nebulizers
        7.2.3 Market Forecast
8   Market Breakup by Treatment Type
    8.1    Quick-Relief Medications
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Long-Term Asthma Control Medications
        8.2.1 Market Trends
        8.2.2 Market Forecast
9   Market Breakup by Route of Administration
    9.1    Inhalation
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Oral
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Parenteral
        9.3.1 Market Trends
        9.3.2 Market Forecast
10  Market Breakup by Region
    10.1    North America
        10.1.1 United States
           10.1.1.1 Market Trends
           10.1.1.2 Market Forecast
        10.1.2 Canada
           10.1.2.1 Market Trends
           10.1.2.2 Market Forecast
    10.2    Asia Pacific
        10.2.1 China
           10.2.1.1 Market Trends
           10.2.1.2 Market Forecast
        10.2.2 Japan
           10.2.2.1 Market Trends
           10.2.2.2 Market Forecast
        10.2.3 India
           10.2.3.1 Market Trends
           10.2.3.2 Market Forecast
        10.2.4 South Korea
           10.2.4.1 Market Trends
           10.2.4.2 Market Forecast
        10.2.5 Australia
           10.2.5.1 Market Trends
           10.2.5.2 Market Forecast
        10.2.6 Indonesia
           10.2.6.1 Market Trends
           10.2.6.2 Market Forecast
        10.2.7 Others
           10.2.7.1 Market Trends
           10.2.7.2 Market Forecast
    10.3    Europe
        10.3.1 Germany
           10.3.1.1 Market Trends
           10.3.1.2 Market Forecast
        10.3.2 France
           10.3.2.1 Market Trends
           10.3.2.2 Market Forecast
        10.3.3 United Kingdom
           10.3.3.1 Market Trends
           10.3.3.2 Market Forecast
        10.3.4 Italy
           10.3.4.1 Market Trends
           10.3.4.2 Market Forecast
        10.3.5 Spain
           10.3.5.1 Market Trends
           10.3.5.2 Market Forecast
        10.3.6 Russia
           10.3.6.1 Market Trends
           10.3.6.2 Market Forecast
        10.3.7 Others
           10.3.7.1 Market Trends
           10.3.7.2 Market Forecast
    10.4    Latin America
        10.4.1 Brazil
           10.4.1.1 Market Trends
           10.4.1.2 Market Forecast
        10.4.2 Mexico
           10.4.2.1 Market Trends
           10.4.2.2 Market Forecast
        10.4.3 Others
           10.4.3.1 Market Trends
           10.4.3.2 Market Forecast
    10.5    Middle East and Africa
        10.5.1 Market Trends
        10.5.2 Market Breakup by Country
        10.5.3 Market Forecast
11  SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis
    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14  Price Analysis
15  Competitive Landscape
    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    AstraZeneca
           15.3.1.1 Company Overview
           15.3.1.2 Product Portfolio 
           15.3.1.3 Financials 
           15.3.1.4 SWOT Analysis
        15.3.2    Abbott
           15.3.2.1 Company Overview
           15.3.2.2 Product Portfolio
           15.3.2.3 Financials 
           15.3.2.4 SWOT Analysis
        15.3.3    Amgen Inc.
           15.3.3.1 Company Overview
           15.3.3.2 Product Portfolio 
           15.3.3.3 Financials 
           15.3.3.4 SWOT Analysis
        15.3.4    Biogen Inc.
           15.3.4.1 Company Overview
           15.3.4.2 Product Portfolio 
           15.3.4.3 Financials 
           15.3.4.4 SWOT Analysis
        15.3.5    Boehringer Ingelheim GmbH
           15.3.5.1 Company Overview
           15.3.5.2 Product Portfolio 
        15.3.6    F. Hoffmann-La Roche AG
           15.3.6.1 Company Overview
           15.3.6.2 Product Portfolio 
           15.3.6.3 SWOT Analysis
        15.3.7    GlaxoSmithKline Plc.
           15.3.7.1 Company Overview
           15.3.7.2 Product Portfolio
           15.3.7.3 Financials 
           15.3.7.4 SWOT Analysis
        15.3.8    Merck & Co. Inc.
           15.3.8.1 Company Overview
           15.3.8.2 Product Portfolio 
           15.3.8.3 Financials 
           15.3.8.4 SWOT Analysis
        15.3.9    Novartis AG
           15.3.9.1 Company Overview
           15.3.9.2 Product Portfolio
           15.3.9.3 Financials 
           15.3.9.4 SWOT Analysis
        15.3.10    Sunovion Pharmaceuticals Inc. (Dainippon Sumitomo Pharma Co. Ltd.)
           15.3.10.1 Company Overview
           15.3.10.2 Product Portfolio 
           15.3.10.3 SWOT Analysis
        15.3.11    Teva Pharmaceutical Industries Ltd.
           15.3.11.1 Company Overview
           15.3.11.2 Product Portfolio 
           15.3.11.3 Financials 
           15.3.11.4 SWOT Analysis
 
List of Figures

Figure 1: Global: Asthma Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Asthma Therapeutics Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Asthma Therapeutics Market: Breakup by Drug Class (in %), 2020
Figure 4: Global: Asthma Therapeutics Market: Breakup by Product Type (in %), 2020
Figure 5: Global: Asthma Therapeutics Market: Breakup by Treatment Type (in %), 2020
Figure 6: Global: Asthma Therapeutics Market: Breakup by Route of Administration (in %), 2020
Figure 7: Global: Asthma Therapeutics Market: Breakup by Region (in %), 2020
Figure 8: Global: Asthma Therapeutics Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 9: Global: Asthma Therapeutics (Anti-Inflammatory Drugs) Market: Sales Value (in Million US$), 2015 & 2020
Figure 10: Global: Asthma Therapeutics (Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 11: Global: Asthma Therapeutics (Bronchodilators) Market: Sales Value (in Million US$), 2015 & 2020
Figure 12: Global: Asthma Therapeutics (Bronchodilators) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 13: Global: Asthma Therapeutics (Combination Therapy) Market: Sales Value (in Million US$), 2015 & 2020
Figure 14: Global: Asthma Therapeutics (Combination Therapy) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 15: Global: Asthma Therapeutics (Inhalers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 16: Global: Asthma Therapeutics (Inhalers) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 17: Global: Asthma Therapeutics (Nebulizers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 18: Global: Asthma Therapeutics (Nebulizers) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 19: Global: Asthma Therapeutics (Quick-Relief Medications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 20: Global: Asthma Therapeutics (Quick-Relief Medications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 21: Global: Asthma Therapeutics (Long-Term Asthma Control Medications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 22: Global: Asthma Therapeutics (Long-Term Asthma Control Medications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 23: Global: Asthma Therapeutics (Inhalation) Market: Sales Value (in Million US$), 2015 & 2020
Figure 24: Global: Asthma Therapeutics (Inhalation) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 25: Global: Asthma Therapeutics (Oral) Market: Sales Value (in Million US$), 2015 & 2020
Figure 26: Global: Asthma Therapeutics (Oral) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 27: Global: Asthma Therapeutics (Parenteral) Market: Sales Value (in Million US$), 2015 & 2020
Figure 28: Global: Asthma Therapeutics (Parenteral) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 29: North America: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 30: North America: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 31: United States: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 32: United States: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 33: Canada: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 34: Canada: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 35: Asia Pacific: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 36: Asia Pacific: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 37: China: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 38: China: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 39: Japan: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 40: Japan: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 41: India: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 42: India: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 43: South Korea: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 44: South Korea: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 45: Australia: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 46: Australia: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 47: Indonesia: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 48: Indonesia: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 49: Others: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 50: Others: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 51: Europe: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 52: Europe: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 53: Germany: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 54: Germany: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 55: France: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 56: France: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 57: United Kingdom: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 58: United Kingdom: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 59: Italy: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 60: Italy: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 61: Spain: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 62: Spain: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 63: Russia: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 64: Russia: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 65: Others: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 66: Others: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 67: Latin America: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 68: Latin America: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 69: Brazil: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 70: Brazil: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 71: Mexico: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 72: Mexico: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 73: Others: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 74: Others: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 75: Middle East and Africa: Asthma Therapeutics Market: Sales Value (in Million US$), 2015 & 2020
Figure 76: Middle East and Africa: Asthma Therapeutics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 77: Global: Asthma Therapeutics Industry: SWOT Analysis
Figure 78: Global: Asthma Therapeutics Industry: Value Chain Analysis
Figure 79: Global: Asthma Therapeutics Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: Global: Asthma Therapeutics Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Asthma Therapeutics Market Forecast: Breakup by Drug Class (in Million US$), 2021-2026
Table 3: Global: Asthma Therapeutics Market Forecast: Breakup by Product Type (in Million US$), 2021-2026
Table 4: Global: Asthma Therapeutics Market Forecast: Breakup by Treatment Type (in Million US$), 2021-2026
Table 5: Global: Asthma Therapeutics Market Forecast: Breakup by Route of Administration (in Million US$), 2021-2026
Table 6: Global: Asthma Therapeutics Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 7: Global: Asthma Therapeutics Market Structure
Table 8: Global: Asthma Therapeutics Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

The global asthma therapeutics market was valued at US$ 17.6 Billion in 2020. 

We expect the global asthma therapeutics market to exhibit a CAGR of 1.60% during 2021-2026.

The increasing prevalence of asthma, along with continuous improvements in the diagnostic technologies, are driving the global asthma therapeutics market. 

Sudden outbreak of the COVID-19 pandemic has led to the increasing adoption of asthma therapeutics as severe respiratory diseases, such as coronavirus infection, can worsen asthma symptoms. 

Based on the drug class, the global asthma therapeutics market can be segmented into anti-inflammatory drugs, bronchodilators, and combination therapies. Currently, combination therapies hold the majority of the total market share.

Based on the product type, the global asthma therapeutics market has been segregated into inhalers and nebulizers where, nebulizers currently represent the largest segment.

Based on the route of administration, the global asthma therapeutics market can be segmented into inhalation, oral and parenteral. Among these, inhalation accounts for the largest market share.

On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market. 

Some of the major players in the global asthma therapeutics market include AstraZeneca, Abbott, Amgen Inc., Biogen Inc., Boehringer Ingelheim GmbH, F. Hoffmann-La Roche AG, GlaxoSmithKline plc., Merck & Co. Inc., Novartis AG, Sunovion Pharmaceuticals Inc. (Dainippon Sumitomo Pharma Co. Ltd.) and Teva Pharmaceutical Industries Ltd.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Related Report

Enzymes Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Hereditary Angioedema Therapeutic Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Veterinary Service Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Animal Wound Care Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Anti-Obesity Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Read More

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )

Drop us an email at

sales@imarcgroup.com

Social Links